Market News & Insights

Point And Figure Chart: Crude Oil Oversold, But Bearish

After a nice rally off the March lows, Crude Oil is struggling again… so much so that it is testing those March lows already. For now, Crude Oil is oversold and likely to bounce, but the Point And Figure chart below for WTIC doesn’t look promising at all. The recent collapse in prices has taken it’s toll. Crude Oil Point & Figure Chart It appears that the sharp rally that

Apple Stock (AAPL) Falls Again: Testing Key Price Support Level

For the past two years or so, investors have had it pretty easy with Apple (AAPL). There have been a few scares, but mostly sunny skies. But the recent decline in shares has fallen below a key technical price indicator and is nearing an important juncture in time and price. In sum, if AAPL doesn’t find its footing soon, it may risk a deeper drop. After years of active investing,

Energy Roundup: Natural Gas Looks Weak, Crude Oil Near Lows

Natural Gas prices appear to be at a critical point point in time (see NG futures chart below). The YTD chart of Natural Gas prices indicates that a key trend line off of a multi-year low put in place on April 27 is in jeopardy of being broken. And that could spell trouble for NG. Natural Gas prices found support in June and July on this line. Compounding the potential

Unusual Options Activity: 5 Stock To Watch (TWTR, BKS, NFX, MDLZ, VMEM)

Unusual Options Activity Report Here’s a quick look at 5 stocks showing unusual options activity with some color around the trading setups and recent news about the companies. Barnes & Noble (BKS) – The Sep $24/$26/$30 bull call spread risk reversal was put on 1,840 times for a $0.55 debit. A trade like this one involves buying the Sep $26/$30 bull call spread and selling the Sep $24 puts for

Markets Tame As The Fed Serves The Porridge Just Right

The market likes some level of “certainty”… especially when it feels like the market has been lacking it. Enter the Fed today. As expected, the Fed held rates unchanged. But what about the rest of the FOMC statement? Well, the Fed statement was carefully crafted/hedged (as usual), with mention of a strengthening labor market and the possibility of a rate increase… perhaps even this year. The usual. And how did the market perceive

Will Rising Existing Home Prices Begin To Slow Sales?

There is a dichotomy between U.S. sales of new and existing homes. This has been preceded by a dichotomy between how their median prices were diverging from each other. June saw existing home sales jump to a seasonally adjusted annual rate of 5.49 million units – the highest since 5.79 million in February 2007 (see chart 1 below). New home sales, however, fell to a seasonally adjusted annual rate of

Chart Of The Day: Chinese Stock Market ETF (FXI) Crushed

The Shanghai Stock Exchange (SSEC) fell 8.5 percent overnight highlighting just how unsettled investors are in that market. That drop has translated to a 4.3 percent drop on the iShares China ETF (FXI) as the U.S. markets near the last 30 minutes of the trading day. I’m not all that surprised because the original 30 percent selloff created a lot of overhead supply. So even though we saw a sharp rally

U.S. Corn Weekly Review: Corn Futures Feel The Fade

This was without question a tough week for Corn Bulls. Monday’s price action showcased a 15 ¼-cent lower close in December corn futures ($4.16), which resulted in CZ5 closing at its lowest level since June 29th. What is the significance of June 29th? It was the last trading day prior to the release of the June Acreage and June Stocks reports, which collectively prompted December corn futures to enter their acceleration phase

Can Biogen Regain Its Mojo? BIIB Earnings On Tap…

Biogen has lagged the scorching hot biotech group this summer. Why? Well, Wednesday Biogen Idec (BIIB) announced some apparently disappointing data on its Alzheimer’s drug. Look for more color on that during Thursday’s Biogen earnings report conference call, a report that will now be watched by many Biotech investors. How BIIB earnings are received coupled with what they say on their Alzheimer’s drug will likely move the Biogen stock. According